Finance

Beta
Lists
9995:HKG
Remegen Ord Shs H
HK$70.50
-2.62%
(-1.90) 1D
Jun 5, 4:09:10 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 9995...
Open
HK$73.75
High
HK$75.10
Low
HK$70.25
Mkt. cap
58.01B
Avg. vol.
3.55M
Volume
3.20M
P/E ratio
47.22
52-wk high
HK$126.60
52-wk low
HK$44.05
EPS
HK$1.49
No. of employees
3K
Open
HK$73.75
High
HK$75.10
Low
HK$70.25
Mkt. cap
58.01B
Avg. vol.
3.55M
Volume
3.20M
P/E ratio
47.22
52-wk high
HK$126.60
52-wk low
HK$44.05
EPS
HK$1.49
No. of employees
3K
News stories
From sources across the web
About Remegen Ord Shs H
CEOJianmin Fang
Employees3.05K
FoundedJul 4, 2008
Headquarters-
SectorBiotechnology
Websiteremegen.cn
Last report
Apr 28, 2026
Fiscal period
Q1 2026
EPS / Est. (CNY)
- / -
Revenue / Est. (CNY)
656.21M / -
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
571.98M
621.88M
1.53B
656.21M
Cost of goods sold
86.99M
95.57M
144.90M
116.96M
Cost of revenue
86.99M
95.57M
144.90M
116.96M
Research and development expenses
318.33M
243.37M
328.16M
209.86M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
331.22M
366.19M
437.44M
355.27M
Operating expense
653.66M
613.06M
764.11M
561.33M
Total operating expenses
740.65M
708.64M
909.01M
678.29M
Operating income
-168.66M
-86.76M
622.21M
-22.08M
Other non operating income
3.04M
-3.60M
4.44M
3.05M
EBT including unusual items
-195.42M
-101.13M
1.26B
328.49M
EBT excluding unusual items
-191.18M
-98.47M
615.48M
-31.29M
Income tax expense
-
-
748.69K
486.54K
Effective tax rate
-
-
0.06%
0.15%
Other operating expenses
1.13M
-1.60M
60.85K
1.78M
Net income
-195.42M
-101.13M
1.26B
328.01M
Net profit margin
-34.17%
-16.26%
82.31%
49.98%
Earnings per share
-
-
-
-
Interest and investment income
959.05K
1.13M
1.02M
1.10M
Interest expense
-20.52M
-15.23M
-13.13M
-13.36M
Net interest expenses
-19.56M
-14.10M
-12.10M
-12.26M
Depreciation and amortization charges
-
-
-
-
EBITDA
-105.33M
-29.01M
685.23M
40.94M
Gain or loss from assets sale
-178.55K
178.55K
771.57K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more